Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa

被引:19
|
作者
Jassat, Waasila [1 ,2 ]
Karim, Salim S. Abdool [3 ,4 ]
Ozougwu, Lovelyn [1 ,2 ]
Welch, Richard [1 ,2 ]
Mudara, Caroline [1 ]
Masha, Maureen [1 ,2 ]
Rousseau, Petro [5 ]
Wolmarans, Milani [5 ]
Selikow, Anthony [6 ]
Govender, Nevashan [1 ]
Walaza, Sibongile [1 ,7 ]
von Gottberg, Anne [1 ,8 ]
Wolter, Nicole [1 ,8 ]
Pisa, Pedro Terrence [2 ,9 ]
Sanne, Ian [2 ,10 ]
Govender, Sharlene [2 ]
Blumberg, Lucille [1 ,2 ]
Cohen, Cheryl [1 ]
Groome, Michelle J. [1 ,8 ]
机构
[1] Natl Inst Communicable Dis, Div Natl Hlth Lab Serv, 1 Modderfontein Rd, ZA-2192 Johannesburg, South Africa
[2] Right Care, Pretoria, South Africa
[3] Ctr AIDS Programme Res South Afr, Durban, South Africa
[4] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA
[5] Natl Dept Hlth, Pretoria, South Africa
[6] CSIR, Pretoria, South Africa
[7] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa
[8] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa
[9] Univ Pretoria, Fac Hlth Sci, Dept Human Nutr & Dietet, Pretoria, South Africa
[10] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Clin HIV Res Unit, Johannesburg, South Africa
关键词
COVID-19; hospital admissions; mortality; Omicron BA; 4; 5;
D O I
10.1093/cid/ciac921
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Admission incidence risk and in-hospital mortality decreased in the Omicron BA.1/BA.2 wave, reducing even further in the Omicron BA.4/BA.5 wave. Mortality risk was lower in those with natural infection and vaccination, declining further as the number of vaccine doses increased. Background In this study, we compared admission incidence risk and the risk of mortality in the Omicron BA.4/BA.5 wave to previous waves. Methods Data from South Africa's SARS-CoV-2 case linelist, national COVID-19 hospital surveillance system, and Electronic Vaccine Data System were linked and analyzed. Wave periods were defined when the country passed a weekly incidence of 30 cases/100 000 population. In-hospital case fatality ratios (CFRs) during the Delta, Omicron BA.1/BA.2, and Omicron BA.4/BA.5 waves were compared using post-imputation random effect multivariable logistic regression models. Results The CFR was 25.9% (N = 37 538 of 144 778), 10.9% (N = 6123 of 56 384), and 8.2% (N = 1212 of 14 879) in the Delta, Omicron BA.1/BA.2, and Omicron BA.4/BA.5 waves, respectively. After adjusting for age, sex, race, comorbidities, health sector, and province, compared with the Omicron BA.4/BA.5 wave, patients had higher risk of mortality in the Omicron BA.1/BA.2 wave (adjusted odds ratio [aOR], 1.3; 95% confidence interval [CI]: 1.2-1.4) and Delta wave (aOR, 3.0; 95% CI: 2.8-3.2). Being partially vaccinated (aOR, 0.9; 95% CI: .9-.9), fully vaccinated (aOR, 0.6; 95% CI: .6-.7), and boosted (aOR, 0.4; 95% CI: .4-.5) and having prior laboratory-confirmed infection (aOR, 0.4; 95% CI: .3-.4) were associated with reduced risks of mortality. Conclusions Overall, admission incidence risk and in-hospital mortality, which had increased progressively in South Africa's first 3 waves, decreased in the fourth Omicron BA.1/BA.2 wave and declined even further in the fifth Omicron BA.4/BA.5 wave. Mortality risk was lower in those with natural infection and vaccination, declining further as the number of vaccine doses increased.
引用
收藏
页码:1468 / 1475
页数:8
相关论文
共 50 条
  • [1] Performance of rapid antigen tests in identifying Omicron BA.4 and BA.5 infections in South Africa
    Samsunder, Natasha
    Lustig, Gila
    de Vos, Margaretha
    Ngcapu, Sinaye
    Giandhari, Jennifer
    Tshiabuila, Derek
    San, Emmanuel James
    Lewis, Lara
    Kharsany, Ayesha B. M.
    Cawood, Cherie
    de Oliveira, Tulio
    Karim, Quarraisha Abdool
    Karim, Salim Abdool
    Escadafal, Camille
    Naidoo, Kogieleum
    Sivro, Aida
    JOURNAL OF CLINICAL VIROLOGY, 2023, 165
  • [2] Update on the omicron sub-variants BA.4 and BA.5
    Tallei, Trina Ekawati
    Alhumaid, Saad
    AlMusa, Zainab
    Fatimawali
    Kusumawaty, Diah
    Alynbiawi, Ahlam
    Alshukairi, Abeer N.
    Rabaan, Ali A.
    REVIEWS IN MEDICAL VIROLOGY, 2023, 33 (01)
  • [3] Analytical Sensitivity of Lateral Flow Devices against SARS-CoV-2 Omicron Subvariants BA.4, BA.5, and BA.2.75
    Mackenzie, Charlene
    Batty, Mitchell
    Papadakis, Georgina
    Stevens, Laura
    Yoga, Yano
    Taiaroa, George
    Stefanatos, Helen
    Savic, Ivana
    Tran, Thomas
    Deerain, Joshua
    Prestedge, Jacqueline
    Druce, Julian
    Caly, Leon
    Williamson, Deborah A.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2022, 60 (11)
  • [4] Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4/BA.5 omicron predominance in Thailand
    Intawong, Kannikar
    Chariyalertsak, Suwat
    Chalom, Kittipan
    Wonghirundecha, Thanachol
    Kowatcharakul, Woravut
    Thongprachum, Aksara
    Chotirosniramit, Narain
    Noppakun, Kajohnsak
    Khwanngern, Krit
    Teacharak, Worachet
    Piamanant, Prapon
    Khammawan, Pimpinan
    Iamsirithaworng, Sopon
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2023, 56 (06) : 1178 - 1186
  • [5] Emergence of omicron variant's sublineages BA.4 and BA.5: risks assessment and possible countermeasures
    Dhawan, Manish
    Saied, AbdulRahman A.
    Bin Emran, Talha
    Choudhary, Om Prakash
    NEW MICROBES AND NEW INFECTIONS, 2022, 48
  • [6] Early Detection of SARS-CoV-2 Omicron BA.4 and BA.5 in German Wastewater
    Wilhelm, Alexander
    Agrawal, Shelesh
    Schoth, Jens
    Meinert-Berning, Christina
    Bastian, Daniel
    Orschler, Laura
    Ciesek, Sandra
    Teichgraeber, Burkhard
    Wintgens, Thomas
    Lackner, Susanne
    Weber, Frank-Andreas
    Widera, Marek
    VIRUSES-BASEL, 2022, 14 (09):
  • [7] The epidemiology and phylogenetic trends of Omicron subvariants from BA.5 to XBB.1 in Taiwan
    Tsai, Jih-Jin
    Chiou, Shyh-Shin
    Chen, Po-Chih
    Chen, Chun-Hong
    Lin, Ping-Chang
    Tsai, Ching-Yi
    Chuang, Wan-Long
    Hwang, Shang-Jyh
    Chong, Inn-Wen
    Liu, Li-Teh
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2024, 17 (11)
  • [8] Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults
    Kopel, Hagit
    Nguyen, Van Hung
    Boileau, Catherine
    Bogdanov, Alina
    Winer, Isabelle
    Ducruet, Thierry
    Zeng, Ni
    Bonafede, Mac
    Esposito, Daina B.
    Martin, David
    Rosen, Andrew
    van de Velde, Nicolas
    Vermund, Sten H.
    Gravenstein, Stefan
    Mansi, James A.
    VACCINES, 2023, 11 (11)
  • [9] Structural Insight into the Resistance of the SARS-CoV-2 Omicron BA.4 and BA.5 Variants to Cilgavimab
    Fujita, Shigeru
    Kosugi, Yusuke
    Kimura, Izumi
    Yamasoba, Daichi
    Sato, Kei
    VIRUSES-BASEL, 2022, 14 (12):
  • [10] Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data
    Russo, Antonio
    Grimaldi, Pierantonio
    Pisaturo, Mariantonietta
    Onorato, Lorenzo
    Coppola, Nicola
    FRONTIERS IN IMMUNOLOGY, 2024, 15